期刊
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH
卷 17, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13018-022-03194-2
关键词
Liuwei Dihuang pill; Diabetic osteoporosis; Network pharmacology; Molecular mechanism; Bioinformatics analysis; Pharmaceutical discovery
类别
资金
- Sanming Project of Medicine in Shenzhen [SZSM201512043]
- Natural Science Foundation of Ningxia Hui Autonomous Region [2022AAC03398]
The study investigated the active components, signaling pathways, and potential mechanisms of Liuwei Dihuang pill (LDP) in the treatment of diabetic osteoporosis using network pharmacology approaches. The results indicate that LDP may treat diabetic osteoporosis through multiple targets and signaling pathways.
Background Diabetic osteoporosis (DOP) is one of the chronic complications of diabetes mellitus, but without a standardized treatment plan till now. Liuwei Dihuang pill (LDP) has gradually exerted a remarkable effect on DOP in recent years; its specific mechanism is not clear yet. Methods We adopted network pharmacology approaches, including multi-database search, pharmacokinetic screening, network construction analysis, gene ontology enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway analysis and molecular docking to elaborate the active components, signaling pathways and potential mechanisms of LDP in the treatment of DOP. Results Twenty-seven active ingredients and 55 related disease targets have been found through integrated network pharmacology. Functional enrichment analysis shows that five key active ingredients, including beta-sitosterol, stigmasterol, diosgenin, tetrahydroalstonine, and kadsurenone, may give full scope to insulin secretion estrogen-level raising and angiogenesis in biological process through the pivotal targets. In addition, the underlying effect of PI3K/AKT/FOXO and VEGF pathways is also suggested in the treatment. Conclusion Based on systematic network pharmacology methods, we predicted the basic pharmacological effects and potential mechanisms of LDP in the treatment of DOP, revealing that LDP may treat DOP through multiple targets and multiple signaling pathways, which provide evidence for the further study of pharmacological mechanism and broader clinical thinking.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据